According to recent filings covering the 90 days ending February 10, 2026, the three most significant insider holders at Lexicon Pharmaceuticals are Director International S.C.A. Artal (136.18Mn shares), Director Raymond Debbane (6.84Mn shares), Director Us Partners Llc Invus (5.45Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| International S.C.A. Artal | 136,180,481 | 14 May, 2024 | |
| Raymond Debbane | 6,836,893 | 13 May, 2025 | |
| Us Partners Llc Invus | 5,451,204 | 09 Aug, 2022 | |
| Lonnel Coats | Chief Executive Officer | 1,098,068 | 29 Feb, 2024 |
| Global Management, Llc Invus | 367,145 | 04 Feb, 2026 | |
| Alan J Main | Evp And Innov & Chem Sciences | 339,104 | 03 Mar, 2025 |
| Jeffrey L Wade | President And Cfo | 324,214 | 29 Feb, 2024 |
| Philippe Amouyal | 285,174 | 13 May, 2025 | |
| Brian T Crum | Svp And General Counsel & Secr. | 260,815 | 03 Mar, 2025 |
| Christopher J Sobecki | 203,865 | 13 May, 2025 | |
| Kenneth B. Kassler-Taub | Svp And Regulatory & Qa | 162,672 | 29 Feb, 2024 |
| Sam L Barker | 124,459 | 13 May, 2025 | |
| Wendy Mcdermott | Svp And Human Resources | 121,646 | 03 Mar, 2025 |
| Craig B Granowitz | Svp And Chief Medical Officer | 120,252 | 03 Mar, 2025 |
| Judith L Swain | 85,174 | 13 May, 2025 | |
| Kristen Alexander | Vp And Finance And Accounting | 76,368 | 03 Mar, 2025 |
| Kiernan Seth | Vp And Chief Commercial Officer | 53,136 | 01 Mar, 2023 |
| Robert J Md Lefkowitz | 48,364 | 29 Apr, 2024 | |
| Alan S Nies | 41,046 | 22 May, 2023 | |
| Frank Palantoni | 40,332 | 22 May, 2023 | |
| Diane E. Sullivan | 36,810 | 13 May, 2025 | |
| Lisa Defrancesco | Svp And Ir And Corp Comm | 15,577 | 03 Mar, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Feb, 2026 | Global Management, Llc Invus | Common Stock | A | 3,846,154 | $1.30 | 7,362,368 | I | A |
| 02 Feb, 2026 | Global Management, Llc Invus | Series B Convertible Preferred Stock | A | 367,145 | $65.00 | 367,145 | I | A |
| 02 Feb, 2026 | Global Management, Llc Invus | Common Stock | A | 1,538,462 | $1.30 | 1,538,462 | I | P |
| 02 Feb, 2026 | Global Management, Llc Invus | Common Stock | A | 18,553,846 | $1.30 | 154,734,327 | I | A |
| 13 May, 2025 | Raymond Debbane | Common Stock | A | 36,810 | $0.00 | 1,385,689 | D | M |
| 13 May, 2025 | Christopher J Sobecki | Common Stock | A | 36,810 | $0.00 | 203,865 | D | M |
| 13 May, 2025 | Sam L Barker | Common Stock | A | 36,810 | $0.00 | 124,459 | D | M |
| 13 May, 2025 | Philippe Amouyal | Common Stock | A | 36,810 | $0.00 | 285,174 | D | M |
| 13 May, 2025 | Judith L Swain | - | - | 85,174 | D | |||
| 13 May, 2025 | Judith L Swain | Common Stock | A | 36,810 | $0.00 | 85,174 | D | M |
| 13 May, 2025 | Diane E. Sullivan | Common Stock | A | 36,810 | $0.00 | 36,810 | D | M |
| 28 Feb, 2025 | Alan J Main | Common Stock | D | 43,434 | $0.67 | 339,104 | D | F |
| 28 Feb, 2025 | Alan J Main | Common Stock | A | 25,667 | - | 281,391 | D | M |
| 28 Feb, 2025 | Alan J Main | - | - | 339,104 | D | |||
| 28 Feb, 2025 | Alan J Main | Common Stock | A | 68,243 | - | 382,538 | D | M |
| 28 Feb, 2025 | Alan J Main | Common Stock | A | 32,904 | - | 314,295 | D | M |
| 28 Feb, 2025 | Brian T Crum | - | - | 306,437 | D | |||
| 28 Feb, 2025 | Brian T Crum | Common Stock | A | 33,456 | - | 237,050 | D | M |
| 28 Feb, 2025 | Brian T Crum | Common Stock | A | 26,097 | - | 203,594 | D | M |
| 28 Feb, 2025 | Brian T Crum | - | - | 203,594 | D |